All SARS-CoV-2 articles
-
News
Nasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19 is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA).
-
News
Virus that causes COVID-19 increases risk of cardiac events
A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of cardiovascular events.
-
News
New method offers faster response to new virus variants
Researchers present a promising approach for swift identification of mutations that are crucial for the immune escape that enables the rapid adaptation of vaccines to new virus variants. It is based on a previously established method called mutational scanning.
-
News
Study investigates ozonated water’s effectiveness against SARS-CoV-2 in saliva
A research group examined the human salivary organic components, amylase, mucin, and urea, and ozonated water’s effect on SARS-CoV-2 in the presence of these components.
-
News
Ventilation in hospitals could cause viruses to spread further
Increased use of ventilation and air cleaners, designed to mitigate the spread of viral infections in hospitals, is likely to have unpredictable effects and may cause viral particles to move around more, according to a new study.
-
News
Researchers in Brazil discover a gene that may afford protection against COVID-19
During the pandemic, health worker Maria Tereza Malheiros Sapienza’s curiosity was aroused by her immunity to SARS-CoV-2, even though her husband was infected twice. A new study reveals that an overexpression of IFIT3 protein was responsible.
-
News
New tool can detect fast-spreading SARS-COV-2 variants before they take off
By analysing millions of viral genome sequences from around the world, a team of scientists has uncovered the specific mutations that give SARS-CoV-2 a ‘turbo boost’ in its ability to spread.
-
News
Papers outline 4 advances for inactivating infectious viruses and bacteria
Four papers provide insights into novel antiviral compounds and methods to inactivate infectious viral particles and bacteria.
-
News
Japan’s ‘soft’ but not ineffective approach to public health during the COVID-19 pandemic
Researchers found that risk perception and infection prevention behaviors rose during Japan’s COVID-19 state of emergency. After it was lifted, hygienic behaviors persisted, but dread risk perception declined.
-
News
A new vaccine approach could help combat future coronavirus pandemics
Researchers are able to create a mosaic nanoparticle vaccine - mosaic-8, based on the sarbecovirus receptor-binding proteins (RBDs), which would help combatting SARS-CoV-2 variants and other coronavirus subtypes.
-
News
Scientists discover molecular ‘fingerprint’ of Long Covid in children’s blood
A new study has highlighted the molecular signature of Long Covid in plasma in paediatric age and used an AI tool capable of making the diagnosis based on the results of the blood sample with 93% accuracy.
-
News
Scientists develop new 'twindemic' diagnostic system for rapid viral testing
A team of scientists has recently developed a novel TwinDemic Detection (TDD) system, designed for simultaneous detection of SARS-CoV and influenza A virus (IAV).
-
News
New research provides insight into reduced COVID-19 vaccine efficacy in lupus patients
A recent study provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases, highlighting that lupus patients may require tailored vaccination strategies.
-
News
Genetic mutation linked to higher SARS-CoV-2 risk
Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus’ ability to invade human cells.
-
News
Study finds cases of ME/CFS increase following SARS-CoV-2
New findings suggest that infection with SARS-CoV-2, the virus that causes COVID-19, may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
-
News
The role of understudied dysfunctional immune cells in severe COVID-19: new research
A new study focuses on understanding how ‘notoriously understudied’ immune cells behave abnormally in patients with severe COVID-19 and provides insights into mechanism behind COVID-19 disease progression.
-
News
Pediatric investigation study confirms the safety of COVID-19 vaccination during pregnancy
A new study shows that maternal COVID-19 vaccination is not associated with adverse health outcomes in infants.
-
News
A dial for tuning the immune system: Discovery sheds light on why COVID makes some sicker than others
A new study identifies an “immune system tuning dial,” which originated as a bug in the genetic code tens of millions of years ago. When this signaling goes awry and leads the body to under or overreact, people are more likely to develop severe or Long COVID.
-
News
A new class of antivirals could help prevent future pandemics
A new study introduces a proof-of-concept for a novel class of antivirals that would target a type of enzyme essential not just to SARS, but also many RNA viruses, including Ebola and dengue, as well as cytosolic-replicating DNA viruses, including Pox viruses.
-
News
New study reveals how COVID-19 variants hijack human cells
A research team has successfully mapped what they call the “hijackome”, detailing how SARS-CoV-2 variants exploit specific cellular pathways.